Telik Updates ASSIST-1 Status
Tue, 26 Sep 2006 07:00 AM EST
... Telik, Inc. (Nasdaq: TELK) announced today that the pre-specified number of events have been reached on the ASSIST-1 Phase 3 trial in platinum refractory or resistant ovarian cancer. Telik, Inc. of Palo Alto, CA is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. [click link for full article] ...

Not Signed In -


